本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc Series A P

9.04
-0.3701-3.93%
盘后9.270.2300+2.54%16:00 EDT
成交量:2.68万
成交额:24.58万
市值:3,098.10万
市盈率:-4.12
高:9.67
开:9.58
低:8.85
收:9.41
52周最高:9.85
52周最低:4.72
股本:342.71万
流通股本:342.71万
量比:0.79
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-2.1959
每股收益(LYR):-2.6890
净资产收益率:-746.25%
总资产收益率:-32.37%
市净率:1.39
市盈率(LYR):-3.36

数据加载中...

公司资料

公司名字:
Fortress Biotech Inc Series A P
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
- -
邮编:
- -
电话:
- -
传真:
- -
简介:
- -

董事

名称
职位
Eric K. Rowinsky
Vice Chairman of the Board of Director
Lindsay A. Rosenwald
Chairman of the Board of Director, President and Chief Executive Officer
Michael S. Weiss
Executive Vice Chairman Strategic Development and Director
Dov Klein
Director
J. Jay Lobell
Director
Jimmie Harvey, Jr.
Director
Kevin Lorenz
Director
Malcolm Hoenlein
Director

股东

名称
职位
Lindsay A. Rosenwald
Chairman of the Board of Director, President and Chief Executive Officer
George Avgerinos
Senior Vice President, Biologics Operations
Robyn M. Hunter
Chief Financial Officer
Michael S. Weiss
Executive Vice Chairman Strategic Development and Director